Subscribe to Search results

The Terrence Higgins Trust was founded.

Published on:

Dr James Smith of the Plasma Fractionation Laboratories provided a written statement to the Penrose Inquiry in relation to viral inactivation in the period up to 1985.

Published on:

In the course of his judgment, Lord Justice Gibson said: "The plaintiffs have set out, in my judgment, a prima facie case to the effect that the Department knew or should have known of the risk to the plaintiffs from the use of concentrate obtained from suppliers in the United States".

Published on:

A meeting was held by the UKHCDO to discuss the HIV Haemophilia litigation.

Published on:

The number of claims by people with haemophilia for compensation in Scotland was 29.

Published on:

David Watters of the Haemophilia Society wrote to Kenneth Clarke, Secretary of State for Health, stating that the £10 million which had been given to the Macfarlane Trust was not enough.

Published on:

The first of a number of versions of a statement of claim in the HIV Haemophilia litigation was served.

Published on:

Richard Gutowski was working at the Medicines Control Agency at this time. He later became the team leader of the Department of Health's blood policy team.

Published on:

Richard Gutowski sent a fax to Mike Arthur seeking to resist any form of settlement, because to settle implied an admission of liability and risked encouraging further litigation and public pressure for similar settlements out of court.

Published on:

Mike Arthur was a higher executive officer working with John Canavan in the section responsible for policy regarding blood supply and blood safety. John Canavan reported to Malcolm Harris and later Charles Dobson.

Published on:

The Canada Diseases Weekly Report published a report titled "Reduction of AIDS Risk: Recommendations for Physicians Treating Hemophiliac Patients".

Published on:

Professor Willem Van Aken, responsible for production at the Central Laboratory for Blood Transfusion of the national service in Amsterdam, gave evidence to the Lindsay Inquiry regarding the collection of blood and plasma in the 1980s.

Published on:

John Petricciani sent a memo to all licensed manufacturers of plasma derivatives on behalf of the FDA and Department of Human and Health Services, setting out an appropriate approach by which to decrease the potential risk of transmitting AIDS by plasma derivatives.

Published on:

Lee Stay was investigated at Lord Mayor Treloar Hospital and College, where Dr Anthony Aronstam was the lead clinician, for signs of AIDS.

Published on:

Lee Stay had three different commercial concentrates as well as some NHS product when attending Treloar's.

Published on:

Testing was a general pattern at Treloar's.

Published on:

The Lancet published an article by Professor Ludlam and others on "Disorder Immune Regulation in Haemophiliacs not Exposed to Commercial Factor VIII".

Published on:

An article titled "Immunological Abnormalities in Haemophilia - Are They Caused by American Factor VIII Concentrate?" by Froebel et al was published in the British Medical Journal, which argued against a disease vector specific to American blood products.

Published on:

An article titled "AIDS surveillance in haemophilia" by Daly et al was published in the British Journal of Haematology.

Published on:

Dr Robert Gallo's team in the US identified the Cytopathic Retroviruses virus as the presumptive cause of AIDS and named it HTLV-3.

Published on: